| Date Filed | Type | Description |
| 12/21/2022 |
SC 13G
| Rosalind Advisors, Inc. reports a 6.1% stake in MEDIWOUND LTD. |
| 12/21/2022 |
SC 13D/A
| Rosalind Advisors, Inc. reports a 9.9% stake in Delcath Systems, Inc. |
| 11/02/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 10% stake in Cellectar Biosciences, Inc. |
| 07/21/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/06/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/09/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2022 |
SC 13D/A
| Rosalind Advisors, Inc. reports a 9.9% stake in Delcath Systems, Inc. |
| 02/14/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 1.5% stake in PhaseBio Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 0% stake in PLx Pharma Inc. |
| 02/11/2022 |
SC 13G
| Rosalind Advisors, Inc. reports a 5.8% stake in Galera Therapeutics, Inc. |
| 01/21/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 10% stake in Cellectar Biosciences, Inc. |
| 01/20/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 6.5% stake in UNICYCIVE THERAPEUTICS, INC. |
| 01/20/2022 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 8.1% stake in Myomo, Inc. |
| 09/23/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/08/2021 |
SC 13G
| Rosalind Advisors, Inc. reports a 6% stake in Cellectar Biosciences, Inc. |
| 06/25/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/19/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/19/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/06/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/22/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/22/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/18/2020 |
SC 13G
| Rosalind Advisors, Inc. reports a 5.4% stake in VistaGen Therapeutics, Inc. |
| 05/13/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/11/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/06/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/01/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/24/2019 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 2.9% stake in Chiasma, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/10/2018 |
SC 13G
| Rosalind Advisors, Inc. reports a 8.3% stake in Auris Medical Holding AG |
|